The UroLift® System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men 50 years of age or older.
The UroLift® System should not be used if you have:
If you have a known allergy to nickel, talk to your doctor about your allergy before getting a UroLift® procedure.
Most patients do not typically require a catheter post-procedure, but it is possible that you may. If needed, the catheter typically only stays in for an average of about one day.
Recovery times vary but patients typically experience rapid symptom relief and a return to normal activity within a few days. Your doctor will discuss any restrictions in your specific situation.
The most common side effects which may include light blood in the urine, some pain or discomfort when urinating, some increased urge to go and discomfort in the pelvis that typically resolve within two to four weeks after the procedure.
To date, there has been no evidence of new sustained erectile or ejaculatory dysfunction reported following a UroLift procedure.
Non-clinical testing has demonstrated that the UroLift® Implant is MR Conditional. That means that you can be safely scanned in an MR system meeting the following conditions:
Under the scan conditions defined above, the UroLift® is expected to produce a maximum temperature rise of 2.4°C after 15 minutes of continuous scanning.
In non-clinical testing, the image artifact caused by the device extends approximately 15 mm from the UroLift® Implant when imaged with a gradient echo pulse sequence and a 3 Tesla MRI system.
Patient implant cards are provided to inform the patient that the UroLift® implant is MR Conditional and can safely be scanned only under specific MR conditions.
If you have any questions about MRI safety, please consult your doctor.